Gapping down
In reaction to earnings/guidance:
- CGNT -22.4%, CNXC -5.1%, JEF -2.6% (also authorizes new $250 mln share repurchase program), NKE -1.9% (also authorizes new $18 bln share repurchase program)
Other news:
- JAZZ -3.8% (Top-line Results from Phase 3 Trial Evaluating Nabiximols Oromucosal Spray)
- HOOD -3.4% (FTX CEO says co not having any active M&A conversations with HOOD according to MarketWatch)
- TAL -1.9% (Provides Update on Status under Holding Foreign Companies Accountable Act)
- LZB -0.9% (Lovesac and Joybird resolve patent litigation)
- STT -0.8% (discusses stress test results to increase dividend by 10% to begin its existing share repurchase program in Q4)
- PHG -0.7% (provides update on Philips Respironics' PE-PUR sound abatement foam test and research program)
Analyst comments:
- FTCH -2.6% (downgraded to Neutral from Buy at UBS)
- EBAY -2.4% (downgraded to Neutral from Buy at UBS)
- EPZM -1.4% (downgraded to Market Perform from Outperform at Cowen)